References
- Chiorazzi N, Rai K, Ferranini M. Chronic lymphocytic leukaemia. N Eng J Med 2005; 352: 804–815
- Dighiero G. CLL Biology and prognosis. Hematology Am Soc Hematol Educ Program 2005; 3: 278–284
- Montserrat E. New prognostic markers in CLL. Hematology Am Soc Hematol Educ Program 2006; 3: 279–284
- Rosenwald A, Alizadeh A, Widhopf G, Simon R, Davis R, Yu X, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 1639–1647
- Orchard J, Ibbotson R, Best G, Parker A, Oscier D. ZAP-70 in B cell malignancies. Leuk Lymphoma 2005; 46: 1689–1698
- Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003; 348: 1764–1775
- Durig J, Nuckel H, Cremer M, Fuhrer A, Halfmeyer K, Fandrey J, et al. ZAP-70 expression is a prognostic factor in chronic lymphocytic. Leukaemia 2003; 17: 2426–2434
- Rassenti L, Huynh L, Toy T L, Chen L, Keating M, Gribben J, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004; 351: 893–901
- Del Principe M, Del Poeta G, Buccisano F, Maurillo L, Venditti A, Zuchetto A, et al. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukaemia. Blood 2006; 108: 853–861
- Shanafelt T, Witzig T, Fink S, Jenkins R, Paternoster S, Smoley S, et al. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukaemia. J Clin Oncol 2006; 24: 4634–4661
- Chen Z, Aston E, Yu M. Loss of ZAP 70 and low molecular weight phosphotyrosine phosphatase occurs after therapy in a patient with B-chronic lymphocytic leukemia. Leukemia 2005; 19: 1503–1505
- Chaar B, Grosso L, Petruska P. Variability of ZAP 70 expression in a patient with CLL. Am J Hematology 2006; 81: 645
- Schroers R, Griesinger F, Trumper L, Haase D, Kulle B, Klein-Hitpass L, et al. Combined analysis of ZAP70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 2005; 19: 750–758
- Orchard J, Ibbotson R, Davis Z, Wiestner A, Rosenwald A, Thomas P, et al. ZAP70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004; 363: 105–111
- Hamblin T, Orchard J, Ibbotson R, Davis Z, Thomas P, Stevenson F, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002; 99: 1023–1029